NEW YORK, Jan. 21 - GenoMed on Friday said it has signed a Letter of Intent with the DW Coordinating Center to buy 50 Caucasian samples of "common, serious diseases."

DWCC, a global contract-research group with research ties to Eastern Europe based in Los Altos, Calif., will obtain blood samples from patients with "common diseases" like hypertension, myocardial infarction, stroke, and some cancers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.